Prime Medicine (PRME) is currently experiencing significant short-selling pressure, with 27.9% of its float held short. The daily short volume ratio of 74% indicates that a large portion of the daily trading volume is being driven by short sales. With a borrow fee of 0.5% and a days-to-cover ratio of 6.3, the stock is showing signs of a sustained bearish outlook. The high short volume ratio, combined with the stock's presence on the FINRA threshold list, suggests that there is significant settlement-level pressure. Traders should watch for any changes in the borrow fee, as a spike could indicate a tightening of lendable shares and potential for increased volatility.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.